Recap: Bio-Techne Q4 Earnings

Shares of Bio-Techne TECH were unchanged after the company reported Q4 results.

Quarterly Results

Earnings per share fell 20.00% year over year to $1.00, which beat the estimate of $0.75.

Revenue of $175,834,000 declined by 8.26% from the same period last year, which beat the estimate of $163,910,000.

Guidance

Earnings guidance hasn't been issued by the company for now.

Bio-Techne hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Aug 04, 2020

Time: 09:00 AM

ET Webcast URL: http://public.viavid.com/player/index.php?id=140692

Technicals

52-week high: $286.68

52-week low: $155.17

Price action over last quarter: Up 22.56%

Company Description

Bio-Techne Corp is a life science manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The protein sciences division's key products (78% of sales) include proteins, antibodies, and assays as well as equipment and associated consumables for protein characterization and analysis. The remaining revenue in the diagnostics and genomics segment is roughly split between manufacturing creates controls, calibrators, and reagents for diagnostic manufacturers combined with proprietary molecular and genetic testing kits. The company is split into two reporting segments namely, Protein Sciences segment and Diagnostics and Genomics segment. The Protein Sciences segment generates maximum revenue for the company.